Contrast-enhanced high resolution magnetic resonance imaging of pigmented malignant melanoma using Mn-TPPS4 and Gd-DTPA: Experimental results

Melanoma Research

Volumn 10, Issue 1, 2000, Pages 40-46

  Maurer J ^a,c   Strauss, A ^a,c   Ebert, W ^b,c   Bauer, H ^b,c   Felix, R ^a,c  

^a HUMBOLDT UNIVERSITY   (Germany)

^b BAYER PHARMA AG   (Germany)

^c Radiologie am Prinzregentenplatz   (Germany)

Author keywords

Contrast medium; Gd DTPA; High resolution; Magnetic resonance imaging; Melanoma; Metalloporphyrin; MnTPPS4

Indexed keywords

GADOLINIUM PENTETATE; METALLOPORPHYRIN;

ANIMAL CELL; ARTICLE; CONTRAST ENHANCEMENT; IMAGE ANALYSIS; MALIGNANT NEOPLASTIC DISEASE; MELANOMA CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PRIORITY JOURNAL; SIGNAL NOISE RATIO; SKIN PIGMENTATION; TISSUE DISTRIBUTION; TUMOR GROWTH;

EID: 0034050701     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200010010-00006     Document Type: Article

References (25)

1. 31P NMR using surface coils. Nature 1980; 283: 167-170.
2. 2. Sarna T, Sealy RC. Free radicals from eumelanins: quantum yields and wavelength dependence. Arch Biochem Biophys 1984; 232(2): 574-578.
3. 3. Bockhorst K, Hoehn-Berlage M, Ernestus RI, Tolxdorff T, Hossmann KA. NMR-contrast enhancement of experimental brain tumors with MnTPPS: qualitative evaluation by in vivo relaxometry. Magn Reson Imaging 1993; 11: 655-663.
4. 4. Furmanski P, Longley C. Metalloporphyrin enhancement of magnetic resonance imaging of human tumor xenografts in nude mice. Cancer Res 1988; 48: 4604-4610.
5. 5. Mäurer J, Knollmann FD, Veuskens Ch, Ebert W, Bauer H, Felix R. Contrast enhanced high resolution MRI of cutaneous melanoma using Gd-DTPA and Gd-DTPA-polylysine: experimental results. Skin Res Technol 1998; 4: 49-53.
6. 6. Droege RT, Wiener SN, Rzeszotarski MS. A strategy for magnetic resonance imaging of the head: results of a semi empirical model. Radiology 1984; 153: 419-434.
7. 7. Bittoun J, Saint-Jalmes H, Querleux BG, Darrasse L, Jolivet O, Idy-Peretti I, Wartski M, Richard SB, Leveque J-L. In vivo high-resolution MR imaging of the skin in a whole-body system at 1,5 T. Radiology 1990; 176: 457-460.
8. 8. Hyde JS, Jesmanowicz A, Kneeland JB. Surface coil for MR imaging of the skin. Magn Reson Med 1987; 5: 456-461.
9. 9. Querleux B, Yasmine MM, Darrasse L, Saint-Jalmes H, Sauzade M, Leveque JL. Magnetic resonance imaging of the skin. A comparison with the ultrasonic technique. Bioeng Skin 1988; 4: 1-14.
10. 10. Richard S, Querleux B, Bittoun J, Jolivet O, Idy-Peretti I, de Lacharriere O, Leveque J-L. Characterisation of the skin in vivo by high-resolution MR imaging: water behaviour and age-related effect. J Invest Dermatol 1993; 100: 705-709.
11. 11. Felix R, Schörner W, Laniado M, Niendorf H-P, Claussen C, Fiegler W, Speck U. Brain tumors: MR imaging with gadolinium-DTPA. Radiology 1985; 156: 681-688.
12. 12. Kaiser WA, Zeitler E. MR-imaging of the breast: fast imaging sequences with and without Gd-DTPA. Radiology 1989; 170: 681-686.
13. 13. Mihara F, Gupta KL, Murayama S, Lee N, Bond JB, Haik BG. MR imaging of malignant uveal melanoma: role of pulse sequence and contrast agent. AJNR 1991; 12: 991-996.
14. 14. Adam G, Brab M, Bohndorf K, Klose K-C, Günther RW. Kontrastmittelunterstützte MRT maligner Aderhautmelanome. Fortschr Röntgenstr 1991; 3: 275-280.
15. 15. Erlemann R, Sciuk J, Wuisman P, Bene D, Edel G, Ritter J, Peters PE. Dynamische MR-Tomographie in der Diagnostik entzündlicher und tumoröser Raumforderungen des muskuloskelettalen Systems. Fortschr Röntgenstr 1992; 4: 353-359.
16. 16. Fiel RJ, Musser DA, Mark EH, Mazurchuk R, Alletto JJ. A comparative study of manganese meso-sulfonatophenyl porphyrins: contrast-enhancing agents for tumors. Magn Reson Imaging 1990; 8: 255-259.
17. 17. Ogan MD, Revel D, Brasch RC. Metalloporphyrin contrast enhancement of tumors in magnetic resonance imaging. A study of human carcinoma, lymphoma, and fibrosarcoma in mice. Invest Radiol 1987; 22: 822-828.
18. 18. Takahashi M, Kohda H. Diagnostic utility of magnetic resonance imaging in malignant melanoma. J Am Acad Dermatol 1992; 27: 51-54.
19. 19. Zemtsov A, Lorig R, Bergneid WF, Bailin PL, Ng TC. Magnetic resonance imaging of cutaneous melanocytic lesions. Oncology 1989; 15: 854-858.
20. 20. Breslow A. Thickness, cross-sectional area and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970; 172: 902-908.
21. 21. Bond JB, Haik BG, Mihara F, Gupta KL. Magnetic resonance imaging of choroidal melanoma with and without gadolinium contrast enhancement. Ophthalmology 1991; 98: 459-466.
22. 22. Erlemann R, Reiser MF, Peters PE, Vasallo P, Nommensen B, Kusnierz-Glaz CR, Ritter J, Roessner. Musculoskeletal neoplasms: static and dynamic Gd-DPTA-enhanced MR imaging. Radiology 1989; 171: 767-773.
23. 23. Cohen JS, Lyon R. Metalloporphyrins as potential contrast agents in magnetic resonance imaging. In: Contrast Agents in Magnetic Resonance Imaging. Proceedings of an International Workshop, January 1986, San Diego, California, USA, pp. 35-40.
24. 24. Mäurer J, Knollmann FD, Schlums D, Garbe C, Vogl TJ, Bier J, Felix R. Role of high-resolution magnetic resonance imaging for differentiating melanin-containing skin tumors. Invest Radiol 1995; 30(11): 638-643.
25. 25. Place DA, Faustino PJ, van Zijl PCM, Chesnick A, Cohen JS. Metalloporphyrins as contrast agents for tumors in magnetic resonance imaging. Invest Radiol 1990; 25: 69-70.